GKB Ophthalmics Quarterly Results for Trading Insights
GKB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹2 Cr
QSept 2025
GKB Ophthalmics Quarterly Results Key Highlights
- Revenue of ₹31 Cr in Sept 2025 (+0.0% vs Mar 2025, +19.2% vs Sept 2024)
- Net Profit of ₹2 Cr in Sept 2025 (+150.0% vs Mar 2025, +300.0% vs Sept 2024)
- EBITDA of ₹3 Cr in Sept 2025 (+200.0% vs Mar 2025)
- Operating Margin of 10.0% in Sept 2025 (+19.0pp vs Mar 2025)
- Earnings Per Share of ₹3.17 in Sept 2025 (+145.1% vs Mar 2025)
GKB Ophthalmics Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 31 | 31 | 33 | 58 | 26 | - | 19.2% |
| Net Profit (₹ Cr) | 2 | -4 | -1 | 1 | -1 | - | - |
| EBITDA (₹ Cr) | 3 | -3 | 1 | 2 | 0 | - | - |
| EPS (₹) | 3.17 | -7.03 | -2.02 | 0.08 | -2.41 | - | - |
| Operating Margin (%) | 10.0% | -9.0% | 2.0% | 2.0% | 0.0% | - | - |
GKB Ophthalmics Share Price Trend Around Quarterly Results
Visualize GKB Ophthalmics's 1-year price movement across quarterly results — ideal for logging trades in GKB Ophthalmics share price
chart using Tickjournal. All values in ₹.
Related Pages for GKB Ophthalmics
Additional stock information and data for GKB
Revenue Trend (₹ Cr)
Dec 2025
58
Jun 2025
33
Mar 2025
31
Sept 2025
31
Net Profit Trend (₹ Cr)
Dec 2025
1
Jun 2025
-1
Mar 2025
-4
Sept 2025
2
Operating Margin Trend (%)
Dec 2025
2.0%
Jun 2025
2.0%
Mar 2025
-9.0%
Sept 2025
10.0%
Sector Competitors - Quarterly Performance Comparison
Comparing GKB Ophthalmics quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1799.4 | 14,875 | 3,125 | +10.8% | - | 21.0% | 138.4 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6329.0 | 2,860 | 689 | +7.1% | - | 24.1% | 243.7 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4317.8 | 3,219 | 591 | +11.3% | - | 18.4% | 246.2 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1321.2 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.0 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1303.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores